Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
Clinical trial NCT01312363 · COMPLETED
Trial details
- NCT number
- NCT01312363
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.